Bristol-Myers Squibb Company (BMY) Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia  
2/21/2012 6:03:48 AM

PRINCETON, N.J.--(BUSINESS WIRE)--The Bristol-Myers Squibb Foundation has awarded three new grants to improve prevention, diagnosis and care of hepatitis B (HBV) and hepatitis C (HCV) in China and India as part of its Delivering Hopeā„¢: Awareness, Prevention and Care umbrella program which is committed to reducing hepatitis-related health disparities in Asia. China and India together have an estimated 123 million people chronically infected with HBV and 59 million people chronically infected with HCV, accounting for almost 50 percent of all HBV and HCV infections worldwide.